DK432389A - Sulfonamidoalkyl-cykloalkanforbindelser, fremgangsmaade til deres fremstilling samt laegemiddel - Google Patents

Sulfonamidoalkyl-cykloalkanforbindelser, fremgangsmaade til deres fremstilling samt laegemiddel

Info

Publication number
DK432389A
DK432389A DK432389A DK432389A DK432389A DK 432389 A DK432389 A DK 432389A DK 432389 A DK432389 A DK 432389A DK 432389 A DK432389 A DK 432389A DK 432389 A DK432389 A DK 432389A
Authority
DK
Denmark
Prior art keywords
radical
alkyl
sulphonamidoalkyl
cycloalkan
procedures
Prior art date
Application number
DK432389A
Other languages
English (en)
Other versions
DK432389D0 (da
Inventor
Ernst-Christian Witte
Karlheinz Stegmeier
Liesel Doerge
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of DK432389D0 publication Critical patent/DK432389D0/da
Publication of DK432389A publication Critical patent/DK432389A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/38Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • C07D257/06Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Paints Or Removers (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
DK432389A 1988-08-31 1989-08-31 Sulfonamidoalkyl-cykloalkanforbindelser, fremgangsmaade til deres fremstilling samt laegemiddel DK432389A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3829455A DE3829455A1 (de) 1988-08-31 1988-08-31 Sulfonamidoalkyl-cyclohexan-verbindungen, verfahren zu ihrer herstellung sowie arzneimittel

Publications (2)

Publication Number Publication Date
DK432389D0 DK432389D0 (da) 1989-08-31
DK432389A true DK432389A (da) 1990-03-01

Family

ID=6361926

Family Applications (1)

Application Number Title Priority Date Filing Date
DK432389A DK432389A (da) 1988-08-31 1989-08-31 Sulfonamidoalkyl-cykloalkanforbindelser, fremgangsmaade til deres fremstilling samt laegemiddel

Country Status (16)

Country Link
US (2) US5140038A (da)
EP (1) EP0361113B1 (da)
JP (1) JPH02160761A (da)
KR (1) KR900003118A (da)
AT (1) ATE91281T1 (da)
AU (1) AU619335B2 (da)
DD (1) DD287257A5 (da)
DE (2) DE3829455A1 (da)
DK (1) DK432389A (da)
FI (1) FI894069A (da)
HU (1) HUT51251A (da)
IL (1) IL91410A0 (da)
MX (1) MX17338A (da)
NZ (1) NZ230451A (da)
PT (1) PT91577B (da)
ZA (1) ZA896618B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2665440B1 (fr) * 1990-07-31 1994-02-04 Lipha Nouveaux cycloalkylsulfonamides substitues, procedes de preparation et medicaments les contenant.
DE4031821A1 (de) * 1990-10-08 1992-04-09 Boehringer Mannheim Gmbh Verwendung von thromboxan-a2-rezeptoren-antagonisten gegen proliferative veraenderungen in der gefaesswand
US5239082A (en) * 1992-08-03 1993-08-24 Warner-Lambert Company Sulfonamide tetrazole ACAT inhibitors
JPH0753505A (ja) * 1992-10-01 1995-02-28 Hokuriku Seiyaku Co Ltd ベンゼンスルホンアミド誘導体及びその用途
JPH08325248A (ja) * 1995-05-26 1996-12-10 Chugoku Kayaku Kk テトラゾール類の新規な合成試薬及びそれを用いたテトラゾール類の製造方法
JPH0948775A (ja) * 1995-06-02 1997-02-18 Hokuriku Seiyaku Co Ltd (2−チエニル)アルカン酸誘導体
UA59384C2 (uk) 1996-12-20 2003-09-15 Пфайзер, Інк. Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі
US7098361B1 (en) * 2002-11-27 2006-08-29 Martin Donald H Rigid ring amino acids and polyamides there from

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3000377A1 (de) * 1980-01-07 1981-07-09 Boehringer Mannheim Gmbh, 6800 Mannheim Neue sulfonamide, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE3541854A1 (de) * 1985-11-27 1987-06-04 Thomae Gmbh Dr K Neue sulfonylaminoaethylverbindungen, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3535167A1 (de) * 1985-10-02 1987-04-09 Boehringer Mannheim Gmbh Neue sulfonyl-phenyl(alkyl)amine, verfahren zu ihrer herstellung sowie arzneimittel
DE3631824A1 (de) * 1986-02-21 1988-03-31 Bayer Ag Cycloalkano(1.2-b)indol-sulfonamide
DE3610643A1 (de) * 1986-03-29 1987-10-01 Boehringer Mannheim Gmbh Neue phenoxyalkylcarbonsaeure-derivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
DE3623944A1 (de) * 1986-07-16 1988-02-11 Thomae Gmbh Dr K Neue benzolsulfonamido-indanylverbindungen, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3642105A1 (de) * 1986-12-10 1988-06-16 Bayer Ag Substituierte aminomethyl-5,6,7,8-tetrahydronaphtyl-oxyessigsaeuren, neue zwischenprodukte, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
JPH02160761A (ja) 1990-06-20
IL91410A0 (en) 1990-04-29
EP0361113A1 (de) 1990-04-04
DK432389D0 (da) 1989-08-31
NZ230451A (en) 1991-09-25
KR900003118A (ko) 1990-03-23
PT91577A (pt) 1990-03-08
US5407951A (en) 1995-04-18
PT91577B (pt) 1995-05-04
DE58904867D1 (de) 1993-08-12
US5140038A (en) 1992-08-18
AU4024989A (en) 1990-05-17
AU619335B2 (en) 1992-01-23
ATE91281T1 (de) 1993-07-15
FI894069A (fi) 1990-03-01
ZA896618B (en) 1990-06-27
FI894069A0 (fi) 1989-08-30
DE3829455A1 (de) 1990-03-15
DD287257A5 (de) 1991-02-21
MX17338A (es) 1993-11-01
HUT51251A (en) 1990-04-28
EP0361113B1 (de) 1993-07-07

Similar Documents

Publication Publication Date Title
ATE94065T1 (de) Diazepine enthaltende pharmazeutische zusammensetzungen mit plaettchen aktivierender faktor (paf)-antagonistischer wirkung.
HUP0105414A2 (hu) Pirrolo-izokinolin-, azepino- és diazepino-indol-származékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
KR900006342A (ko) 1,4-디아제핀 유도체 및 그의 약학적 이용
HUP0003921A2 (hu) VLA-4 által közvetített leukocitaadhéziót gátló szulfonilezett dipeptidszármazékok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
HUP9901037A2 (hu) Piperazinszármazékok, előállításuk és alkalmazásuk, ezeket a vegyületeket tartalmazó gyógyászati készítmények
YU84791A (sh) Biciklicni 1-aza-cikloalkalni
ES8101536A1 (es) Procedimiento para preparar nuevos derivados de pleuromuti- lin
DK432389A (da) Sulfonamidoalkyl-cykloalkanforbindelser, fremgangsmaade til deres fremstilling samt laegemiddel
ES479820A1 (es) Procedimiento para la preparacion de isoquinoleinas.
ES384015A1 (es) Procedimiento para la preparacion de un medio regulador delcrecimiento de plantas.
DK0544412T3 (da) Rhenium- og technetiumkomplekser indeholdende en hypoxialokaliserende gruppe
DE69107217T2 (de) Oxysulfonylharnstoff-acat-inhibitoren.
ES446993A1 (es) Un procedimiento para la preparacion de nuevos derivados de benzofenona.
IL91648A (en) Amino acid quinoline and naphthyridine derivatives, their preparation and pharmaceutical compositions containing them
ES8601850A1 (es) Un procedimiento para preparar derivados de ciclobutano
ES453162A1 (es) Un procedimiento para la obtencion de compuestos heteroci- clicos.
HUP0301258A2 (hu) Aminoizokinolincsoportot tartalmazó trombin inhibitorok és alkalmazásuk gyógyszerkészítmények előállítására
ES8302718A1 (es) "procedimiento para la preparacion de cetohidroxi-iminocefalosporinas".
ATE500241T1 (de) Phenyl- und pyridyl-piperidine mit tnf-wirkung
DE3361834D1 (en) Dithiino (1,4) (2,3-c) pyrrole derivatives, their preparation and pharmaceutical compositions containing them
DE2963679D1 (en) Clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them
ES485517A1 (es) Un procedimiento para la obtencion de nuevos derivados hete-rociclicos de nitrogeno
AU4878479A (en) Clavulanic acid derivatives
ES402411A1 (es) Procedimiento para la preparacion de derivados de pirimidi-na.
TH20764B (th) อนุพันธ์เฮเทอโรไซคลิคของแอไซโลน